<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1508762</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2025.1508762</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Biological activities and phytochemical characterization of <italic>Sideritis germanicopolitana</italic> subsp. <italic>viridis</italic> and <italic>S. libanotica</italic> subsp. <italic>linearis</italic> extracts and extract-loaded nanoparticles</article-title>
<alt-title alt-title-type="left-running-head">Ta&#x15f;k&#x131;n et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2025.1508762">10.3389/fphar.2025.1508762</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ta&#x15f;k&#x131;n</surname>
<given-names>Turgut</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1865705/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Y&#x131;lmaz</surname>
<given-names>Beyza Nur</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hasan Niari Niar</surname>
<given-names>Shalaleh</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ermano&#x11f;lu</surname>
<given-names>Mizgin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ta&#x15f;k&#x131;n</surname>
<given-names>Duygu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>&#x15e;enkarde&#x15f;</surname>
<given-names>&#x130;smail</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1388844/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>&#x15e;ahin</surname>
<given-names>Talip</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2874874/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>&#xc7;al&#x131;&#x15f;kan Salihi</surname>
<given-names>Elif</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2864681/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sezer</surname>
<given-names>Ali Demir</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/63942/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kerimo&#x11f;lu</surname>
<given-names>Oya</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>El&#xe7;io&#x11f;lu</surname>
<given-names>Hatice K&#xfc;bra</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff11">
<sup>11</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Pharmacognosy</institution>, <institution>Faculty of Pharmacy</institution>, <institution>Marmara University</institution>, <addr-line>Istanbul</addr-line>, <country>T&#xfc;rkiye</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Marmara Pharmacy Drug and Innovative Product Development Unit</institution>, <institution>Faculty of Pharmacy</institution>, <institution>Marmara University</institution>, <addr-line>Istanbul</addr-line>, <country>T&#xfc;rkiye</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Pharnacognosy</institution>, <institution>Institute of Health Sciences</institution>, <institution>Marmara University Istanbul</institution>, <addr-line>Istanbul</addr-line>, <country>T&#xfc;rkiye</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Basic Pharmaceutical Sciences</institution>, <institution>Institute of Health Sciences</institution>, <institution>Marmara University Istanbul</institution>, <addr-line>Istanbul</addr-line>, <country>T&#xfc;rkiye</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Basic Pharmaceutical Sciences</institution>, <institution>Faculty of Pharmacy</institution>, <institution>Marmara University</institution>, <addr-line>Istanbul</addr-line>, <country>T&#xfc;rkiye</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Analytical Chemistry</institution>, <institution>Faculty of Pharmacy</institution>, <institution>University of Health Sciences</institution>, <addr-line>Istanbul</addr-line>, <country>T&#xfc;rkiye</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Department of Pharmaceutical Botany</institution>, <institution>Faculty of Pharmacy</institution>, <institution>Marmara University</institution>, <addr-line>Istanbul</addr-line>, <country>T&#xfc;rkiye</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Department of Biology</institution>, <institution>Institute of Science</institution>, <institution>Ad&#x131;yaman University</institution>, <addr-line>Ad&#x131;yaman</addr-line>, <country>T&#xfc;rkiye</country>
</aff>
<aff id="aff9">
<sup>9</sup>
<institution>Department of Pharmaceutical Biotechnology</institution>, <institution>Faculty of Pharmacy</institution>, <institution>Marmara University</institution>, <addr-line>Istanbul</addr-line>, <country>T&#xfc;rkiye</country>
</aff>
<aff id="aff10">
<sup>10</sup>
<institution>Department of Pharmaceutical Technology</institution>, <institution>Faculty of Pharmacy</institution>, <institution>Marmara University</institution>, <addr-line>Istanbul</addr-line>, <country>T&#xfc;rkiye</country>
</aff>
<aff id="aff11">
<sup>11</sup>
<institution>Department of Pharmacology</institution>, <institution>Faculty of Pharmacy</institution>, <institution>Marmara University</institution>, <addr-line>Istanbul</addr-line>, <country>T&#xfc;rkiye</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/364469/overview">Aleksandra Sknepnek</ext-link>, University of Belgrade, Serbia</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1537640/overview">Aleksandar &#x17d;. Kostic</ext-link>, University of Belgrade, Serbia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2927754/overview">Alena Stupar</ext-link>, University of Novi Sad, Serbia</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Turgut Ta&#x15f;k&#x131;n, <email>turguttaskin@marmara.edu.tr</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>03</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1508762</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>02</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Ta&#x15f;k&#x131;n, Y&#x131;lmaz, Hasan Niari Niar, Ermano&#x11f;lu, Ta&#x15f;k&#x131;n, &#x15e;enkarde&#x15f;, &#x15e;ahin, &#xc7;al&#x131;&#x15f;kan Salihi, Sezer, Kerimo&#x11f;lu and El&#xe7;io&#x11f;lu.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Ta&#x15f;k&#x131;n, Y&#x131;lmaz, Hasan Niari Niar, Ermano&#x11f;lu, Ta&#x15f;k&#x131;n, &#x15e;enkarde&#x15f;, &#x15e;ahin, &#xc7;al&#x131;&#x15f;kan Salihi, Sezer, Kerimo&#x11f;lu and El&#xe7;io&#x11f;lu</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>The current study focuses on evaluating the biological activity and analysis of phytochemical content of extracts and extract-loaded nanoparticles from <italic>Sideritis germanicopolitana</italic> subsp. <italic>viridis</italic> (endemic, SGV) and <italic>S. libanotica</italic> subsp. <italic>linearis</italic> (SLL).</p>
</sec>
<sec>
<title>Methods</title>
<p>Antioxidant activities of extracts and nanoparticles were investigated by DPPH, FRAP and CUPRAC methods. Enzyme inhibition potentials of extracts and nanoparticles were evaluated by Ellman and indophenol methods. Phytochemical contents were analyzed by HPLC-DAD. Plant extracts were encapsulated by the ionic gelation method which was modified in our laboratory using the green chemistry approach.</p>
</sec>
<sec>
<title>Results and Discussion</title>
<p>It was found that the 70% ethanol extracts of SGV and SLL exhibited the highest antioxidant activity in terms of DPPH, FRAP and CUPRAC compared to other extracts. The findings showed that both 70% ethanol extract-loaded nanoparticles obtained from SGV and SLL showed lower DPPH radical scavenging, iron (III) reducing and copper (II) reducing activities compared to crude extracts. It was determined that the 70% extracts of SGV and SLL exhibited a higher potential to inhibit the enzyme urease than other extracts. The anti-urease activity of the nanoparticle loaded with SLL 70% ethanol extract was found to be greater than that of the nanoparticle made with SGV 70% ethanol extract. Furthermore, an analysis of the acetylcholinesterase enzyme inhibition capacity of various extracts from both plants revealed that the 70% ethanol extracts of each plant species had a greater potential for enzyme inhibition than the other extracts. The anticholinesterase activity of the nanoparticle loaded with SLL 70% extract was found to be higher than that of the nanoparticle loaded with SGV 70% ethanol extract. In this study the phenolic metabolites were examined, luteolin (27.44&#xa0;&#x3bc;g/mg extract) and <italic>p</italic>-coumaric acid (20.03&#xa0;&#x3bc;g/mg extract) were found at the highest concentration in the SGV plant while rosmarinic acid (8.70&#xa0;&#x3bc;g/mg extract), caffeic acid (6.46&#xa0;&#x3bc;g/mg extract) and <italic>p</italic>-coumaric acid (4.42&#xa0;&#x3bc;g/mg extract) were found at the highest concentration in the SLL plant. However, the data demonstrated that the nanoparticles had lesser biological activity potential than crude extracts.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The substantial biological activities of the nanoparticles developed as a result of this work showed that these formulations are suitable for use as antioxidant, anti-urease and anticholinesterase medicines in the future due to the benefits of using nanoparticles in the therapeutics such as the controlled release of the active agents and the diminished side effects.</p>
</sec>
</abstract>
<kwd-group>
<kwd>nanoparticles</kwd>
<kwd>biological activity</kwd>
<kwd>medicinal plants</kwd>
<kwd>
<italic>Sideritis germanicopolitana</italic> subsp. <italic>viridis</italic>
</kwd>
<kwd>
<italic>S. libanotica</italic> subsp. <italic>linearis</italic>
</kwd>
<kwd>HPLC-DAD</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Ethnopharmacology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Reactive oxygen species (ROS) and reactive nitrogen species (RNS) have a role in the organism, both harmful and beneficial. In the body, there is a balance between free radicals and endogenous antioxidants, which are in homeostasis. When this balance is disturbed in favor of free radicals (ROS, RNS, etc.), oxidative stress occurs (<xref ref-type="bibr" rid="B51">Valko et al., 2007</xref>; <xref ref-type="bibr" rid="B8">Barja, 2004</xref>; <xref ref-type="bibr" rid="B19">Fang et al., 2002</xref>). As a result, it causes oxidative damage on DNA, RNA, lipids and proteins. This situation is the cause of many diseases such as cardiovascular diseases, ischemic injury, injuries, rheumatoid arthritis, diabetes, Alzheimer&#x2019;s, Parkinson&#x2019;s and especially cancer. In recent studies, oxidative stress has been found to exacerbate the course of coronavirus disease (COVID-19) and complicate the treatment. For this reason, the discovery of exogenous antioxidant agents with high therapeutic effects and low side effects remains important (<xref ref-type="bibr" rid="B7">Bakadia et al., 2021</xref>). <italic>Helicobacter pylori</italic> is a gram-negative microaerophilic bacterium that infects up to 50% of the world&#x2019;s human population. The eradication of <italic>H. pylori</italic> is known to cause gastritis, peptic ulcers, gastric cancers. Through the enzyme urease, <italic>H. pylori</italic> breaks down urea into ammonia and carbon dioxide and colonizes the mucosa by freeing itself from the acidic pH of the gastric surface (<xref ref-type="bibr" rid="B48">Stingl and De Reuse, 2005</xref>; <xref ref-type="bibr" rid="B6">Azizian et al., 2012</xref>; <xref ref-type="bibr" rid="B25">Graham and Miftahussurur, 2018</xref>). Alzheimer&#x2019;s disease (AD) is a cholinergic neurodegenerative disease that affects the brain which is irreversible. It is characterized by progressive loss of memory and general cognitive decline. The cholinergic system is being targeted in the development of anti-Alzheimer medications because it is crucial to the regulation of learning and memory processes. Through the inhibition of the enzyme acetylcholinesterase (AChE), which hydrolyzes acetylcholine, cholinesterase inhibitors directly increase cholinergic transmission. Additionally, it has been demonstrated that in the early phases of senile plaque formation, both butyrylcholinesterase (BuChE) and acetylcholinesterase are crucial for the aggregation of amyloid plaque (<xref ref-type="bibr" rid="B20">Fisher et al., 2012</xref>; <xref ref-type="bibr" rid="B2">Anand and Singh, 2013</xref>; <xref ref-type="bibr" rid="B38">Mishra et al., 2019</xref>).</p>
<p>Phytochemicals undergo digestion and degradation through the mouth, stomach, small and large intestines, then are absorbed from the digestive tract into the blood or lymphatic circulation and further distributed by diffusion or transport into the body circulation, followed by metabolization in body tissues by biochemical transformation or degradation, and final excretion through the renal, biliary or pulmonary pathways (<xref ref-type="bibr" rid="B37">Martinez-Perez et al., 2018</xref>; <xref ref-type="bibr" rid="B30">Holst and Williamson, 2008</xref>). The distribution and absorption of phytochemicals in the small intestine depend on their chemical structure and polarity. Nanoparticles used as carriers are designed to deliver phytochemicals to the target site with enhanced bioactivity. Since nanoparticles contain materials designed at the atomic or molecular level, they are generally small-sized nanostructures. Therefore, they can move more freely in the human body compared to larger materials. Nanotechnology plays a significant role in drug generation and controlled delivery to the target site and controlled release. Therefore, this technology provides numerous benefits in the treatment of chronic human diseases by site-specific and target-oriented delivery of drugs (<xref ref-type="bibr" rid="B32">Jahangirian et al., 2017</xref>; <xref ref-type="bibr" rid="B36">Martinez-Ballesta et al., 2018</xref>; <xref ref-type="bibr" rid="B1">Ahmad et al., 2021</xref>). The genus <italic>Sideritis</italic>, which is a member of Lamiaceae and has aromatic and medicinal properties. This genus is distributed in the Eastern and Western Mediterranean regions, as 46 species grow in the flora of Turkey and 31 of them are endemic (<xref ref-type="bibr" rid="B50">Tepe et al., 2006</xref>; <xref ref-type="bibr" rid="B34">Kan et al., 2018</xref>). Most of the <italic>Sideritis</italic> species grow in the high mountain regions and are called mountain tea by the locals. The infusion of the aerial part of <italic>Sideritis</italic> species is used in traditional folk medicine as a carminative, digestive aid, cough suppressant, diuretic (<xref ref-type="bibr" rid="B56">Formisano et al., 2015</xref>; <xref ref-type="bibr" rid="B44">Sevindik et al., 2021</xref>). <italic>Sideritis</italic> species has been the research subject because it has been used in different treatments for many years. Species belonging to this genus contain terpenes, flavonoids, essential oil, iridoids, coumarins and sterols, which provide this species with a wide range of bioactive effects, especially antimicrobial, antioxidant, antiinflammatory, antispasmodic, antiulcerative, anticonvulsant, carminative, analgesic and sedative effects (<xref ref-type="bibr" rid="B24">Gonz&#xe1;lez-Burgos et al., 2011</xref>; <xref ref-type="bibr" rid="B16">Dincer et al., 2017</xref>). <italic>Sideritis libanotica</italic> subsp. <italic>linearis</italic> (Benth.) Bornm. is species growing in Turkey. The MeOH extract from the aerial parts of the plant was evaluated for its activity in the DPPH<sup>&#x2022;</sup>, ABTS<sup>&#x2022;&#x2b;</sup> and carotene-linoleic acid assays as well as for its total phenolic and flavonoid amounts (<xref ref-type="bibr" rid="B50">Tepe et al., 2006</xref>; <xref ref-type="bibr" rid="B16">Dincer et al., 2017</xref>; <xref ref-type="bibr" rid="B5">Atas et al., 2019</xref>). The perennial plant species <italic>Sideritis germanicopolitana</italic> subsp. <italic>viridis</italic> Hausskn. ex Bornm. is endemic to Turkey and occurs mainly in the Northern Anatolia. Its essential oil has been reported to contain metabolites such as &#x3b1;-pinene, myrcene, sabinene and &#x3b2;-pinene (<xref ref-type="bibr" rid="B40">&#xd6;zkan et al., 2005</xref>; <xref ref-type="bibr" rid="B9">Bayan and Aksit, 2016</xref>). Only a limited number of studies on the biological activity and chemical content of both <italic>Sideritis</italic> species were found in the literature search (<xref ref-type="bibr" rid="B50">Tepe et al., 2006</xref>; <xref ref-type="bibr" rid="B9">Bayan and Aksit, 2016</xref>).</p>
<p>For the formulation of cosmetic, food, and pharmaceutical products which comprised of natural compounds showing biological activities; their stability and shelf life must be enhanced by protecting them from the environmental damage. Compounds such as polyphenols are not stable and make interactions easily, since they have unsaturated bonds in their molecular structure which makes them sensitive to the environmental factors such as oxidants, light exposure, heat, pH, water, and enzymatic activities. In order to protect the ingredients, encapsulation methods have been explored to improve the undesirable properties of the herbal extracts and also to enhance the stability and the delivery of them. The advantages of carrier systems are that, in addition to reducing toxicity, they provide controlled release and increase the bioavailability of the active ingredients (<xref ref-type="bibr" rid="B29">Hcini et al., 2021</xref>; <xref ref-type="bibr" rid="B54">Zeng et al., 2023</xref>). As a result, the objectives of this study are the preparation of <italic>Sideritis germanicopolitana</italic> subsp. <italic>Viridis</italic> and <italic>Sideritis libanotica</italic> subsp. <italic>Linearis</italic> extracts in order to investigate their <italic>in vitro</italic> biological activities; production of extract loaded nanoparticles; characterization of nanoparticles produced; quantitative analysis of phytochemical content of bioactive extracts and extracts-loaded nanoparticles.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 The preparation of plant extracts and the use of plant materials</title>
<p>
<italic>Sideritis germanicopolitana</italic> subsp. <italic>viridis</italic> (SGV) and <italic>Sideritis libanotica</italic> subsp. <italic>linearis</italic> (SLL) species were identified by Assist. Prof. Dr. &#x130;smail &#x15e;enkarde&#x15f;. They were cataloged with the herbarium numbers 19155 and 22,881 and stored in the Faculty of Pharmacy&#x2019;s Herbarium (MARE) at Marmara University. The plant samples were dried at the room temperature. The samples were then extracted by maceration with EtOH:distilled water (70:30) until colorless. Petroleum ether and chloroform extracts were from the crude 70% ethanol extract by liquid-liquid extraction method, respectively. A rotary vacuum evaporator was used to concentrate the six distinct plant extracts. Until examination, all of the extracted materials were kept at &#x2b;4&#xb0;C.</p>
</sec>
<sec id="s2-2">
<title>2.2 Preparation of nanoparticles loaded with plant extracts</title>
<p>Plant extracts were encapsulated by adopting ionic gelation method (<xref ref-type="bibr" rid="B42">Rajaonarivony et al., 1993</xref>) modified in our laboratory using the green chemistry approach. SGV encapsulated nanoparticles (SGV NPs) and SLL encapsulated nanoparticles (SLL NPs) were prepared using sodium alginate (SA) as a natural polymer in aqueous medium without using any additives or surface active agents. Firstly, 1% w/v aqueous solutions of SGV/SLL extracts were prepared and added dropwise into the 2% w/v aqueous solutions of SA in equal volumes under constant stirring. This mixture then added to a 3% w/v calcium chloride bath using the dripping technique. Gelation was observed while dripping and the formed gel was kept in dark medium at room temperature overnight. The next day, after washing with deionized water, the SGV NPs and the SLL NPs were left to dry for 48&#xa0;h at room temperature and under ambient pressure (<xref ref-type="bibr" rid="B55">&#x00C7;a&#x006C;&#x0131;&#x015F;kan Salihi et al., 2025</xref>). After this slow drying process, they were dried at 45&#xb0;C for 4&#xa0;h and the dried nanoparticles were kept at airtight containers. Empty nanoparticles were also prepared using the same procedure for comparison purposes.</p>
</sec>
<sec id="s2-3">
<title>2.3 Characterization of nanoparticles loaded with plant extracts</title>
<p>Fourier-transform infrared (FTIR) spectroscopy was used to analyze the chemical functionalities in the structure of nanoparticle formulation. FTIR spectra of SGV NPs and SLL NPs were obtained from 4,000 to 500&#xa0;cm<sup>&#x2212;1</sup> with an average resolution of 4&#xa0;cm<sup>&#x2212;1</sup> (IRSpirit spectrometer, Shimadzu Corp, Kyoto, Japan). Surface morphology and shape of the nanoparticles were investigated by using Scanning electron microscopy (SEM). The powder samples were mounted on aluminum stubs and the nanoparticles were recorded by using the FEI Quanta 650 FEG SEM device. Sizes of the nanoparticles were measured by using the Zetasizer (Malvern Nano ZS) device applying dynamic light scattering (DLS) technique. Average diameter (Z-average) and the polydispersity index (PDI) of the nanoparticles were measured and compared. The encapsulation efficiency (EE, %) and the Loading capacity (LC, %) were determined by analyzing the filtrate using the UV-Visible Spectrophotometry (Shimadzu 2100S) using the predetermined calibration curves. The EE and the LC were then calculated using the <xref ref-type="disp-formula" rid="e1">Equations 1</xref>, <xref ref-type="disp-formula" rid="e2">2</xref>, which are given below.<disp-formula id="e1">
<mml:math id="m1">
<mml:mrow>
<mml:mtext>EE&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="&#x7c;">
<mml:mrow>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="&#x7c;">
<mml:mrow>
<mml:mtext>Weight&#x2009;of&#x2009;the&#x2009;extract&#x2009;in&#x2009;the&#x2009;NPs</mml:mtext>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mtext>Weight&#x2009;of&#x2009;the&#x2009;extract&#x2009;used</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
<label>(1)</label>
</disp-formula>
<disp-formula id="e2">
<mml:math id="m2">
<mml:mrow>
<mml:mtext>LC&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="&#x7c;">
<mml:mrow>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="&#x7c;">
<mml:mrow>
<mml:mtext>Weight&#x2009;of&#x2009;the&#x2009;extract&#x2009;in&#x2009;the&#x2009;NPs</mml:mtext>
<mml:mo>/</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mtext>Weight&#x2009;of&#x2009;the&#x2009;NPs&#x2009;</mml:mtext>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:math>
<label>(2)</label>
</disp-formula>
<italic>In vitro</italic> release of SGV and SLL from the nanoparticle formulations were studied spectrophotometrically (Shimadzu 2100S) using dialysis bags in PBS (phosphate-buffered saline, pH 7.4) medium. 25&#xa0;mg of each nanoformulations and 50&#xa0;mL of PBS was used for the release experiments. Release experiments were conducted in a thermostatic shaking water bath at 37&#xb0;C. Samples were taken at predetermined time intervals (at 1&#xa0;h, 2&#xa0;h, 3&#xa0;h, 4&#xa0;h, 5&#xa0;h, and 6&#xa0;h) and the concentration of the samples were calculated by spectrophotometric method using the calibration curves prepared initially (<xref ref-type="bibr" rid="B28">Hashem et al., 2022</xref>).</p>
</sec>
<sec id="s2-4">
<title>2.4 Antioxidant activity</title>
<sec id="s2-4-1">
<title>2.4.1 FRAP assays</title>
<p>The FRAP reagent was stored at 37&#xb0;C for 30&#xa0;min. It consisted of 25&#xa0;mL of 300&#xa0;mM acetate buffer (pH 3.6), 2.5&#xa0;mL of TPTZ solution, and 2.5&#xa0;mL of 20&#xa0;mM FeCl<sub>3</sub>. 10&#xa0;&#x3bc;L of extracts/nanoparticles were combined with 190&#xa0;&#xb5;L of FRAP reagent, and after 4&#xa0;min, the mixture&#x2019;s absorbance at 593&#xa0;nm was measured. The extracts&#x2019; FRAP values were presented as mM Fe<sup>2&#x2b;</sup>/mg extract (<xref ref-type="bibr" rid="B10">Benzie and Strain, 1996</xref>).</p>
</sec>
<sec id="s2-4-2">
<title>2.4.2 DPPH assays</title>
<p>240&#xa0;&#xb5;L of DPPH solution (0.1&#xa0;mM) were added to the 10&#xa0;&#xb5;L of extracts/nanoparticles that had been obtained at various doses (0.5&#x2013;3&#xa0;mg/mL). Before being incubated for 30&#xa0;min at 25&#xb0;C, the produced mixtures were stirred for 1&#xa0;min. Every day at 517&#xa0;nm, the mixes&#x2019; absorbance values were measured. Under identical circumstances, the absorbance of the control sample was measured using 10&#xa0;&#xb5;L of methanol rather than the extract. The information gathered throughout the investigation is provided as IC<sub>50</sub> &#x3d; mg/mL (<xref ref-type="bibr" rid="B53">Wei et al., 2010</xref>).</p>
</sec>
<sec id="s2-4-3">
<title>2.4.3 CUPRAC assays</title>
<p>The ability of extracts and nanoparticles to reduce copper (II) ions was evaluated using a method established by Apak et al., in 2004. In a nutshell, 60&#xa0;&#xb5;L of CuCl<sub>2</sub>&#xb7;2H<sub>2</sub>O, 60&#xa0;&#xb5;L of neocuproine, and 60&#xa0;&#xb5;L of 1&#xa0;M NH<sub>4</sub>Ac were mixed, then 60&#xa0;&#xb5;L of the extracts/nanoparticles were added, and finally 10&#xa0;&#xb5;L of ethanol was added to the mixture. The mixes&#x2019; absorbance was spectrophotometrically evaluated at 450&#xa0;nm after 60&#xa0;min against a reference solution that was made by substituting ethanol for the plant extracts. The extracts&#x2019;/nanoparticles&#x2019; CUPRAC values were provided as mg trolox equivalent/mg extract (<xref ref-type="bibr" rid="B4">Apak et al., 2004</xref>).</p>
</sec>
<sec id="s2-4-4">
<title>2.4.4 Total phenolic contents (FCR assay)</title>
<p>25&#xa0;&#xb5;L of extracts, 100&#xa0;&#xb5;L of Folin-Ciocalteu reagent (diluted 1/3 with distilled water) and 75&#xa0;&#xb5;L of 2% sodium carbonate solution were added to the plate. Following this, the mixture was left at room temperature for 2&#xa0;hours and then the absorbance at 750&#xa0;nm was measured by comparison with the reference. The total phenolic content of the extracts was expressed as mg gallic acid equivalents (GAE)/mg extract (<xref ref-type="bibr" rid="B26">G&#xfc;lsoy Toplan, et al., 2022</xref>).</p>
</sec>
</sec>
<sec id="s2-5">
<title>2.5 Enzyme assays</title>
<sec id="s2-5-1">
<title>2.5.1 Anti-urease activity</title>
<p>An enzyme solution (500&#xa0;&#xb5;L) and plant extracts/nanoparticles (100&#xa0;&#xb5;L) were combined and incubated for 30&#xa0;min at 37&#xb0;C. After adding 1,100&#xa0;&#xb5;L of urea to the mixture, it was left in an incubator set to 37&#xb0;C for half an hour. After being taken out of the incubator, the mixture was combined with reagents R<sub>1</sub> (1% phenol, 0.005% sodium nitroprusside) and R<sub>2</sub> (0.5% NaOH, 0.1% sodium hypochlorite), and it was then incubated at 37&#xb0;C for 2&#xa0;hours. The absorbance of the mixture (635&#xa0;nm) was measured in relation to a reference solution that was made by substituting a buffer solution for the urease enzyme solution (<xref ref-type="bibr" rid="B23">Ghous et al., 2010</xref>).</p>
</sec>
<sec id="s2-5-2">
<title>2.5.2 Anticholinesterase activity</title>
<p>Using a microplate reader, the inhibition activities of acetylcholinesterase (AchE) were determined. Acetylthiocholine iodide was utilized as a substrate for the enzyme acetylcholinesterase, which is sourced from electrophorus electricus. The compound used to measure the activity was 5,5-dithiobis-2-nitrobenzoic acid (DTNB), which has a yellow color. Galantamine, an alkaloid-type medication that was extracted from the <italic>Galanthus</italic> plant, was utilized as a control. In summary, 40&#xa0;&#xb5;L of phosphate buffer solution (pH 8.2 0.1&#xa0;M) was mixed with 20&#xa0;&#xb5;L of AchE and various extract/nanoparticles concentrations. For 10&#xa0;minutes, this mixture was incubated at 25&#xb0;C. Following incubation, the mixture was supplemented with 20&#xa0;&#x3bc;L of AcI substrate and 100&#xa0;&#x3bc;L of DTNB. The galantamine that was used as a standard underwent the same process. At 412&#xa0;nm, 5-thio-2nitrobenzoic acid was measured with spectrophotometry. The following formula was used to determine the extracts&#x2019;/nanoparticles anticholinesterase activity as a percentage of inhibition compared to the control (<xref ref-type="bibr" rid="B18">Ellman et al., 1961</xref>). The following formula was used to get the percentage of acetylcholinesterase inhibition: %I &#x3d; (A<sub>control</sub>&#x2013;A<sub>sample</sub>/A<sub>control</sub>)x100.</p>
</sec>
</sec>
<sec id="s2-6">
<title>2.6 HPLC analysis of phytochemical metabolites</title>
<p>High pressure liquid chromatography (HPLC-DAD) system was used to determine the amount of phenolic metabolites contained in the 70% ethanol extracts from plants (Agilent Technologies 1260 Infinity, California, United States). Waters Nova-Pak C18 column (4&#xa0;&#x3bc;m; 3.9 &#xd7; 150&#xa0;mm) was used to separate the metabolites in the plants. The metabolites were analyzed in the HPLC-DAD system using the following conditions: Mobile phase (A) consisted of water and 0.05% formic acid; mobile phase (B) consisted of acetonitrile and 0.05% formic acid. The following gradient program was applied: 0&#xa0;min 5% B; 1&#xa0;min 5% B; 20&#xa0;min 30% B; 25&#xa0;min 60% B; 28&#xa0;min 60% B; 33&#xa0;min 95% B; 35&#xa0;min 95% B; 40&#xa0;min 5% B. 20&#xa0;&#x3bc;L of sample was injected into the system and the flow rate was 0.5&#xa0;mL/min. The obtained 70% ethanol extracts were dissolved in methanol solvent and injected into the HPLC system after being filtered through a 0.45&#xa0;&#x3bc;m syringe tip microfilter (<xref ref-type="bibr" rid="B49">Ta&#x15f;k&#x131;n et al., 2021</xref>).</p>
</sec>
<sec id="s2-7">
<title>2.7 Statistical analysis</title>
<p>The Graphpad Prism 5 program was used to assess the study&#x2019;s data. For p values less than 0.05, statistical differences between research groups were examined using ANOVA and Tukey&#x2019;s multiple comparison test.</p>
</sec>
</sec>
<sec id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 The total phenolic contents</title>
<p>The total phenolic contents of many plant extracts were computed in this investigation. The 70% ethanol extracts from SLL (7.300&#xa0;mg GAE/g extract) and SGV (7.122&#xa0;mg GAE/g extract) had the highest concentration of phenolic metabolites. It is commonly recognized that there is frequently a linear relationship between phenolic chemicals and antioxidant activity. This study indicated that 70% ethanol extracts with abundant phenolic metabolites had better antioxidant activity than other extracts, which was in line with the literature. Furthermore, the total phenolic contents of the nanoparticles loaded with 70% ethanol extract were measured and compared to crude extracts in this investigation. The results indicated that the phenolic content of crude extracts was higher than that of nanoparticles. It was determined that the nanoparticles prepared from the SLL species (1.800&#xa0;mg GAE/g extract) had a higher TPC value than the SGV nanoparticles (0.460&#xa0;mg GAE/g extract) (<xref ref-type="table" rid="T1">Table 1</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Antioxidant activity and total phenolic content of different extracts and extract-loaded nanoparticles.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Assays</th>
<th align="left"/>
<th align="left"/>
<th align="left"/>
<th align="left"/>
<th colspan="2" align="left">Extracts</th>
<th align="left"/>
<th align="left"/>
<th align="left"/>
<th align="left"/>
<th align="left">Standards</th>
</tr>
<tr>
<th align="left"/>
<th align="left"/>
<th align="left"/>
<th align="center">SGV</th>
<th align="left"/>
<th align="left"/>
<th align="left"/>
<th align="left"/>
<th align="left">SLL</th>
<th align="left"/>
<th align="left"/>
<th align="left"/>
</tr>
<tr>
<th align="left"/>
<th align="left">Petroleum<break/>Ether</th>
<th align="left">Chloroform</th>
<th align="left">70% ethanol</th>
<th align="left">70% ethanol loaded nanoparticle</th>
<th align="left">Extract unloaded nanoparticle</th>
<th align="left">Petroleum ether</th>
<th align="left">Chloroform</th>
<th align="left">70% ethanol</th>
<th align="left">70% ethanol loaded nanoparticle</th>
<th align="left">Extract unloadedna noparticle</th>
<th align="left">Ascorbic acid</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">DPPH (IC<sub>50</sub>: mg/mL)</td>
<td align="left">0.149 &#xb1; 0.010&#x2a;</td>
<td align="left">0.056 &#xb1; 0.006&#x2a;</td>
<td align="left">0.028 &#xb1; 0.002&#x2a;</td>
<td align="left">4.421 &#xb1; 1.079&#x2a;</td>
<td align="left">NA</td>
<td align="left">1.891 &#xb1; 1.462&#x2a;</td>
<td align="left">0.041 &#xb1; 0.004&#x2a;</td>
<td align="left">0.039 &#xb1; 0.001&#x2a;</td>
<td align="left">3.154 &#xb1; 0.273&#x2a;</td>
<td align="left">NA</td>
<td align="left">0.004 &#xb1; 0.001</td>
</tr>
<tr>
<td align="left">FRAP (mMFeSO<sub>4</sub>/m g extract)</td>
<td align="left">0.161 &#xb1; 0.005&#x2a;</td>
<td align="left">0.941 &#xb1; 0.051&#x2a;</td>
<td align="left">1.718 &#xb1; 0.094&#x2a;</td>
<td align="left">0.013 &#xb1; 0.001&#x2a;</td>
<td align="left">NA</td>
<td align="left">0.368 &#xb1; 0.045&#x2a;</td>
<td align="left">1.297 &#xb1; 0.152&#x2a;</td>
<td align="left">1.448 &#xb1; 0.015&#x2a;</td>
<td align="left">0.018 &#xb1; 0.002&#x2a;</td>
<td align="left">NA</td>
<td align="left">7.808 &#xb1; 0.353</td>
</tr>
<tr>
<td align="left">CUPRAC (mMTE/mg extract)</td>
<td align="left">0.194 &#xb1; 0.032&#x2a;</td>
<td align="left">1.306 &#xb1; 0.238&#x2a;</td>
<td align="left">2.538 &#xb1; 0.011&#x2a;</td>
<td align="left">0.022 &#xb1; 0.012&#x2a;</td>
<td align="left">NA</td>
<td align="left">0.481 &#xb1; 0.030&#x2a;</td>
<td align="left">2.128 &#xb1; 0.180&#x2a;</td>
<td align="left">2.278 &#xb1; 0.182&#x2a;</td>
<td align="left">0.030 &#xb1; 0.028&#x2a;</td>
<td align="left">NA</td>
<td align="left">5.831 &#xb1; 0.068</td>
</tr>
<tr>
<td align="left">Total phenolicconte nt (mgGAE/g extract)</td>
<td align="left">0.016 &#xb1; 0.017</td>
<td align="left">2.759 &#xb1; 0.047</td>
<td align="left">7.122 &#xb1; 0.588</td>
<td align="left">0.460 &#xb1; 0.026</td>
<td align="left">NA</td>
<td align="left">3.325 &#xb1; 0.722</td>
<td align="left">3.797 &#xb1; 0.379</td>
<td align="left">7.300 &#xb1; 0.322</td>
<td align="left">1.800 &#xb1; 0.164</td>
<td align="left">NA</td>
<td align="left"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Ascorbic acid positive control for DPPH, FRAP and CUPRAC, assays; DPPH, 2,2-diphenyl-1-picrylhydrazyl; CUPRAC, cupric ion reducing/antioxidant power; FRAP, ferric reducing antioxidant power; Values are mean of triplicate determination (n &#x3d; 3) &#xb1; standard deviation; &#x2a;P &#x3c; 0.05 compared with the positive control; SGV: <italic>S. germanicopolitana</italic> subsp. <italic>viridis;</italic> SLL<italic>: S. libanotica</italic> subsp. <italic>linearis</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>3.2 Phenolic metabolites analysis</title>
<p>The composition of SGV and SLL extracts was examined both qualitatively and quantitatively since 70% ethanol extracts from plants shown considerable biological activity when compared to other extracts. Quinic acid, 4-hydroxybenzoic acid, chlorogenic acid, vanillic acid, caffeic acid, 2hydroxycinnamic acid, apigenin-7-<italic>O</italic>-neohesperidosid, rosmarinic acid and <italic>p</italic>-coumaric acid were found in the SLL 70% ethanol extract. The highest amounts of rosmarinic acid (8.70&#xa0;&#xb5;g analyte/mg extract), caffeic acid (6.46&#xa0;&#xb5;g analyte/mg extract) and <italic>p</italic>-coumaric acid (4.42&#xa0;&#xb5;g analyte/mg extracts) were determined in the extract of this plants (<xref ref-type="table" rid="T2">Table 2</xref>; <xref ref-type="fig" rid="F1">Figure 1</xref>). Quinic acid, chlorogenic acid, caffeic acid, rosmarinic acid, luteolin, <italic>p</italic>-coumaric acid and 8-hydroxy salvigenin were detected in the SGV 70% ethanol extract. The major metabolites in this species were determined to be luteolin (27.44&#xa0;&#xb5;g analyte/mg extract) and <italic>p</italic>-coumaric acid (20.03&#xa0;&#xb5;g analyte/mg extract) (<xref ref-type="table" rid="T3">Table 3</xref>; <xref ref-type="fig" rid="F1">Figure 1</xref>). In this investigation, chemotype differences between <italic>Sideritis</italic> species were found. 4-hydroxybenzoic acid, vanillic acid, 2- hydroxycinnamic acids, apigenin-7-<italic>O</italic>-neohesperidosid were observed only in the SLL species, while luteolin and 8-hydroxy salvigenin were analyzed in the SGV species. HPLC-DAD findings showed that both SLL (7.46&#xa0;&#xb5;g analyte/mg extract) and SGV (1.79&#xa0;&#xb5;g analyte/mg extract) nanoparticles contained rosmarinic acid. Additionally, 8-hydroxy salvigenin was detected in the nanoparticle of SGV (2.44&#xa0;&#xb5;g analyte/mg extract). It was thought that other phytochemical metabolites found in plants could not be detected because they were not released from the nanoparticles at a rate that could be analyzed by HPLC (<xref ref-type="table" rid="T4">Table 4</xref>; <xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Phenolic metabolites detected in <italic>S. libanotica</italic> subsp. <italic>linearis</italic> extract.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Metabolites</th>
<th align="left">Retention time</th>
<th align="left">Area</th>
<th align="left">Area (%)</th>
<th align="left">&#xb5;g analyte/mg extract</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Quinic acid</td>
<td align="left">6.326</td>
<td align="left">205.60</td>
<td align="left">1.516</td>
<td align="left">0.22 &#xb1; 0.01</td>
</tr>
<tr>
<td align="left">4-Hydroxybenzoic acid</td>
<td align="left">19.336</td>
<td align="left">37.02</td>
<td align="left">0.254</td>
<td align="left">0.30 &#xb1; 0.11</td>
</tr>
<tr>
<td align="left">Chlorogenic acid</td>
<td align="left">21.154</td>
<td align="left">27.70</td>
<td align="left">0.209</td>
<td align="left">3.54 &#xb1; 0.89</td>
</tr>
<tr>
<td align="left">Vanillic acid</td>
<td align="left">21.896</td>
<td align="left">100.23</td>
<td align="left">0.678</td>
<td align="left">0.24 &#xb1; 0.04</td>
</tr>
<tr>
<td align="left">Caffeic acid</td>
<td align="left">29.842</td>
<td align="left">496.29</td>
<td align="left">3.413</td>
<td align="left">6.46 &#xb1; 2.26</td>
</tr>
<tr>
<td align="left">2-Hydroxycinnamic acid</td>
<td align="left">32.996</td>
<td align="left">131.07</td>
<td align="left">0.753</td>
<td align="left">0.47 &#xb1; 0.10</td>
</tr>
<tr>
<td align="left">Apigenin-7-O-neohesperidosid</td>
<td align="left">33.753</td>
<td align="left">176.25</td>
<td align="left">1.289</td>
<td align="left">1.69 &#xb1; 0.06</td>
</tr>
<tr>
<td align="left">Rosmarinic acid</td>
<td align="left">38.034</td>
<td align="left">3,356.30</td>
<td align="left">30.545</td>
<td align="left">8.70 &#xb1; 2.51</td>
</tr>
<tr>
<td align="left">
<italic>p</italic>-Coumaric acid</td>
<td align="left">39.901</td>
<td align="left">959.37</td>
<td align="left">6.909</td>
<td align="left">4.42 &#xb1; 0.51</td>
</tr>
<tr>
<td align="left">Unknown</td>
<td align="left">35.542</td>
<td align="left">1,533.201</td>
<td align="left">11.289</td>
<td align="left">Undetected</td>
</tr>
<tr>
<td align="left">Unknown</td>
<td align="left">36.138</td>
<td align="left">559.383</td>
<td align="left">4.119</td>
<td align="left">Undetected</td>
</tr>
<tr>
<td align="left">Unknown</td>
<td align="left">37.745</td>
<td align="left">2664.812</td>
<td align="left">19.623</td>
<td align="left">Undetected</td>
</tr>
<tr>
<td align="left">Unknown</td>
<td align="left">44.967</td>
<td align="left">867.865</td>
<td align="left">6.390</td>
<td align="left">Undetected</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>HPLC-DAD chromatogram of phenolic and flavonoid compounds detected from <italic>Sideritis</italic> species extracts. <bold>(A)</bold> <italic>S. libanotica</italic> subsp. <italic>linearis</italic> extract; <bold>(B)</bold> <italic>S. germanicopolitana</italic> subsp.<italic>viridis</italic> extract.</p>
</caption>
<graphic xlink:href="fphar-16-1508762-g001.tif"/>
</fig>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Phenolic metabolites detected in <italic>S. germanicopolitana</italic> subsp.<italic>viridis</italic> extract.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Metabolites</th>
<th align="left">Retention time</th>
<th align="left">Area</th>
<th align="left">Area (%)</th>
<th align="left">&#xb5;g analyte/mg extract</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Quinic acid</td>
<td align="left">6.180</td>
<td align="left">440.10</td>
<td align="left">4.037</td>
<td align="left">12.57 &#xb1; 3.88</td>
</tr>
<tr>
<td align="left">Chlorogenic acid</td>
<td align="left">23.506</td>
<td align="left">149.21</td>
<td align="left">1.164</td>
<td align="left">4.35 &#xb1; 0.20</td>
</tr>
<tr>
<td align="left">Caffeic acid</td>
<td align="left">31.840</td>
<td align="left">617.10</td>
<td align="left">5.145</td>
<td align="left">2.28 &#xb1; 0.26</td>
</tr>
<tr>
<td align="left">Rosmarinic acid</td>
<td align="left">32.540</td>
<td align="left">362.86</td>
<td align="left">3.871</td>
<td align="left">1.97 &#xb1; 0.65</td>
</tr>
<tr>
<td align="left">Luteolin</td>
<td align="left">36.210</td>
<td align="left">2930.59</td>
<td align="left">17.5413</td>
<td align="left">27.44 &#xb1; 3.69</td>
</tr>
<tr>
<td align="left">
<italic>p</italic>-Coumaric acid</td>
<td align="left">37.810</td>
<td align="left">1,245.36</td>
<td align="left">8.262</td>
<td align="left">20.03 &#xb1; 4.29</td>
</tr>
<tr>
<td align="left">8-hydroxy salvigenin</td>
<td align="left">40.119</td>
<td align="left">490.90</td>
<td align="left">2.896</td>
<td align="left">2.74 &#xb1; 1.83</td>
</tr>
<tr>
<td align="left">Unknown</td>
<td align="left">35.712</td>
<td align="left">4,393.288</td>
<td align="left">29.999</td>
<td align="left">Undetected</td>
</tr>
<tr>
<td align="left">Unknown</td>
<td align="left">45.091</td>
<td align="left">805.232</td>
<td align="left">5.496</td>
<td align="left">Undetected</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Phenolic metabolites detected in nanoparticles.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="3" align="left">Metabolites &#xb5;g analyte/mg extract</th>
</tr>
<tr>
<th align="left"/>
<th align="left">SGV</th>
<th align="left">SLL</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Rosmarinic acid</td>
<td align="left">1.79 &#xb1; 0.07</td>
<td align="left">7.46 &#xb1; 0.47</td>
</tr>
<tr>
<td align="left">8-hydroxy salvigenin</td>
<td align="left">2.44 &#xb1; 0.16</td>
<td align="left"/>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>HPLC-DAD chromatogram of metabolites detected in nanoparticles. <bold>(A)</bold> <italic>S. libanotica</italic> subsp. <italic>linearis</italic> extract; <bold>(B)</bold> <italic>S. germanicopolitana</italic> subsp.<italic>viridis</italic> extract.</p>
</caption>
<graphic xlink:href="fphar-16-1508762-g002.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>3.3 Antioxidant activity of different extracts and extract-loaded nanoparticle</title>
<p>The antioxidant activities of different extracts from the plant and extract-loaded nanoparticles were comparatively investigated by DPPH, FRAP and CUPRAC methods. It was determined that SGV (IC<sub>50</sub>: 0.028&#xa0;mg/mL) and SLL (IC<sub>50</sub>:0.039&#xa0;mg/mL) 70% ethanol extracts showed the highest DPPH radical scavenging activity compared to other extracts and hence these extract-loaded nanoparticles were prepared and characterized. A second comparison was made between the antioxidant activity of the crude extracts and the nanoparticles. The findings obtained showed that both 70% ethanol extractloaded nanoparticles showed lower DPPH radical scavenging activity than the crude extracts. Upon comparing plant species, it was shown that the nanoparticle loaded with SLL 70% ethanol extract (IC<sub>50</sub>: 3.154&#xa0;mg/mL) has a greater capacity to scavenge free radicals. All plant extracts and extract-loaded nanoparticles demonstrated significantly lower capacity for radical scavenging when compared to ascorbic acid (IC<sub>50</sub>: 0.004&#xa0;mg/mL), which was used as a reference for the potentials of radical scavenging (<xref ref-type="table" rid="T1">Table 1</xref>). The CUPRAC test results (<xref ref-type="table" rid="T1">Table 1</xref>) showed that SGV (2.538&#xa0;mM troloxE/mg extract) and SLL (2.278&#xa0;mM troloxE/mg extract) 70% ethanol extracts have a higher Cu(II) to Cu(I) reduction potential than other extracts. Crude extracts were shown to have higher CUPRAC values than nanoparticles when the CUPRAC values of 70% extract-loaded nanoparticles and crude extracts were evaluated. The findings showed that SLL 70% extract-loaded nanoparticles (0.030&#xa0;mM troloxE/mg extract) showed higher copper (II) ion reduction than SGV 70% extract-loaded nanoparticles (0.022&#xa0;mM troloxE/mg extract). Findings showed that the ascorbic acid (5.831&#xa0;mM troloxE) had a higher Cu(II) to Cu(I) reduction potential than the 70% ethanol extracts and nanoparticles obtained from SGV and SLL. It was discovered that SGV (1.718 mMFeSO<sub>4</sub>/mg extract) and SLL (1.448 mMFeSO<sub>4</sub>/mg extract) 70% ethanol extracts had more iron reducing antioxidant power than other extracts. The extracted-loaded nanoparticles FRAP values were found to be lower than the raw extracts. The iron (III) ion reduction potential of the SLL extract-loaded nanoparticles (0.018 mMFeSO<sub>4</sub>/mg extract) was found to be greater than that of the SGV extract-loaded nanoparticles (0.013 mMFeSO<sub>4</sub>/mg extract). This study also found that the FRAP values of all SGV and SLL extracts and extract-loaded nanoparticles (<xref ref-type="table" rid="T1">Table 1</xref>) were lower than those of ascorbic acid (7.808 mMFeSO<sub>4</sub>).</p>
</sec>
<sec id="s3-4">
<title>3.4 Enzyme inhibition activity of different extracts and extract -loaded nanoparticles</title>
<p>The findings of the comparison of the potentials of the plant extracts and the extract-loaded nanoparticles inhibiting the enzymes acetylcholinesterase and urease are shown in <xref ref-type="table" rid="T5">Table 5</xref>. It was determined that SGV 70% ethanol extract (IC<sub>50</sub>: 0.099&#xa0;mg/mL) and SLL 70% ethanol extract (IC<sub>50</sub>: 0.061&#xa0;mg/mL) had higher urease enzyme inhibition potential than other extracts. The anti-urease activity of the nanoparticles loaded with SLL 70% ethanol extract (IC50: 7.21&#xa0;mg/mL) was found to be greater than that of the nanoparticles made with SGV 70% ethanol extract (IC50: 9.501&#xa0;mg/mL). Crude extracts demonstrated more enzyme inhibition when the potentials of both nanoparticles and crude extracts on the urease enzyme were assessed. It was also observed that unloaded nanoparticles (IC<sub>50</sub>: 12.753&#xa0;mg/mL) showed a certain level of enzyme inhibition and that the activity increased significantly when the extract was loaded. These findings suggested that the polymer (SA) used in nanoparticle preparation have also biological activity potential.</p>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>The ability of different extracts and extract-loaded nanoparticles to inhibit enzymes.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Exctracts/Ass ays</th>
<th align="left"/>
<th align="left"/>
<th align="left">SGV</th>
<th align="left"/>
<th align="left"/>
<th align="left"/>
<th align="left"/>
<th align="left">SLL</th>
<th align="left"/>
<th align="left"/>
<th align="left"/>
<th align="left">Standards</th>
</tr>
<tr>
<th align="left">Petroleum ether</th>
<th align="left">Chloroform</th>
<th align="left">70% ethanol</th>
<th align="left">70% ethanol loaded nanoparticle</th>
<th align="left">Extract unloadedna noparticle</th>
<th align="left">Petroleu m ether</th>
<th align="left">Chloro form</th>
<th align="left">70%ethanol</th>
<th align="left">70% ethanol loadednanoparti cle</th>
<th align="left">Extractunlo aded nanoparticl e</th>
<th align="left">Thiourea</th>
<th align="left">Galantamine</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Urease inhibition (IC<sub>50</sub>:mg/mL)</td>
<td align="left">0.195 &#xb1; 0.019&#x2a;</td>
<td align="left">0.152 &#xb1; 0.135&#x2a;</td>
<td align="left">0.099 &#xb1; 0.028&#x2a;</td>
<td align="left">9.501 &#xb1; 0.054&#x2a;</td>
<td align="left">12.753 &#xb1; 1.674&#x2a;</td>
<td align="left">0.076 &#xb1; 0.002&#x2a;</td>
<td align="left">0.089 &#xb1; 0.033&#x2a;</td>
<td align="left">0.061 &#xb1; 0.024&#x2a;</td>
<td align="left">7.21 &#xb1; 2.940&#x2a;</td>
<td align="left">12.753 &#xb1; 1.674&#x2a;</td>
<td align="left">0.002 &#xb1; 0.001</td>
<td align="left"/>
</tr>
<tr>
<td align="left">Acetylcholine steraseinhibiti on (%) (200&#xa0;&#x3bc;g/mL)</td>
<td align="left">68.53 &#xb1; 0.313&#x2a;</td>
<td align="left">74.623 &#xb1; 1.231&#x2a;</td>
<td align="left">77.137 &#xb1; 0.209&#x2a;</td>
<td align="left">23.508 &#xb1; 0.974&#x2a;</td>
<td align="left">12.441 &#xb1; 1.921&#x2a;</td>
<td align="left">72.574 &#xb1; 0.552&#x2a;</td>
<td align="left">74.262 &#xb1; 1.934&#x2a;</td>
<td align="left">77.895 &#xb1; 2.455&#x2a;</td>
<td align="left">42.726 &#xb1; 7.253&#x2a;</td>
<td align="left">12.441 &#xb1; 1.921&#x2a;</td>
<td align="left"/>
<td align="left">85.289 &#xb1; 0.06</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Thiourea positive control for Urease assays; Galantamine positive control for anticholinesterase assays. Values are mean of triplicate determination (n &#x3d; 3) &#xb1; standard deviation; &#x2a;P &#x3c; 0.05 compared with the positive control; SGV: <italic>S. germanicopolitana</italic> subsp. <italic>viridis;</italic> SLL<italic>: S. libanotica</italic> subsp. <italic>linearis</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Furthermore, an analysis of the acetylcholinesterase enzyme inhibition capacity of various extracts from both plants revealed that the 70% ethanol extracts (SGV:77.137%; SLL: 77.895%) of each plant species had a greater potential for enzyme inhibition than the other extracts. The anticholinesterase activity of the nanoparticles loaded with SLL 70% extract (42.726%) was found to be higher than that of the nanoparticles loaded with SGV 70% ethanol extract (23.508%). The acetylcholinesterase enzyme inhibition potential of the nanoparticles made from both plant species was found to be lower than that of the raw extracts. The presence of a certain degree of enzyme inhibition in unloaded nanoparticles (12.441%) indicated that the polymer utilized in the nanoparticle production process (SA) has biological activity (<xref ref-type="table" rid="T5">Table 5</xref>). The results of this investigation indicated that these formulations could be employed as anti-urease and anticholinesterase medicines in the future, given the benefits of utilizing nanoparticles in the treatment. <xref ref-type="table" rid="T5">Table 5</xref>.</p>
</sec>
<sec id="s3-5">
<title>3.5 Characterization of the nanoparticles</title>
<p>Fourier-transform infrared (FTIR) spectroscopy was used to examine the possible interactions between encapsulated SGV/SLL and the alginate matrix of the nanoparticles. Characteristic peaks of the SA matrix are seen at around 3,300&#xa0;cm<sup>&#x2212;1</sup>, 1,600&#xa0;cm<sup>&#x2212;1</sup>, 1,400&#xa0;cm<sup>&#x2212;1</sup> and 1,000&#xa0;cm<sup>&#x2212;1</sup> in the <xref ref-type="fig" rid="F3">Figure 3</xref>. There are broad bands between 3,000&#xa0;cm<sup>&#x2212;1</sup> and 3,500&#xa0;cm<sup>&#x2212;1</sup> in the spectra of all the nanoparticle samples which shows the O-H bonds of the hydroxyl groups. There are sharp peaks at around 1,600&#xa0;cm<sup>&#x2212;1</sup> representing the asymmetric C&#x3d;O bonds of the COO<sup>&#xaf;</sup> groups. There are also peaks at around 1,400&#xa0;cm<sup>&#x2212;1</sup> representing symmetric bonds of the COO<sup>&#xaf;</sup> groups. There are sharp peaks at around 1,000&#xa0;cm<sup>&#x2212;1</sup> which are attributed to single bonds of the C-O-C stretching vibrations (<xref ref-type="bibr" rid="B12">De Silva et al., 2024</xref>; <xref ref-type="bibr" rid="B11">&#xc7;al&#x131;&#x15f;kan Salihi et al., 2021</xref>; <xref ref-type="bibr" rid="B13">Demirhan et al., 2021</xref>; <xref ref-type="bibr" rid="B52">Wang et al., 2017</xref>). There are no changes were observed in the peak positions after loading of the SGV and SLL which shows the loading of the extracts to the alginate nanoparticles occurred through physical interactions and the extracts were physically dispersed across the alginate chains (<xref ref-type="bibr" rid="B43">Severino et al., 2019</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>FTIR spectra of SGV NPs, SLL NPs and unloaded NPs.</p>
</caption>
<graphic xlink:href="fphar-16-1508762-g003.tif"/>
</fig>
<p>Scanning electron microscopy (SEM) was used to investigate the surface morphology and the sizes of the nanoparticle formulations. SEM images of SGV NPs, SLL NPs and empty NPs were given in <xref ref-type="fig" rid="F4">Figure 4</xref>. The sizes of the samples prepared are at the nanoscale and they have the spherical heterogenous shapes with smooth surfaces which are visibly seen in the SEM images (<xref ref-type="bibr" rid="B3">Anirudhan et al., 2017</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>SEM images of SGV NPs: <bold>(A)</bold>, SLL NPs <bold>(B)</bold> and empty NPs <bold>(C)</bold>.</p>
</caption>
<graphic xlink:href="fphar-16-1508762-g004.tif"/>
</fig>
<p>The particle size analysis of the nanoparticles by dynamic light scattering (DLS) technique are shown in <xref ref-type="fig" rid="F5">Figure 5</xref> as intensity (%) based particle size distribution versus size in nanometers. Results of hydrodynamic size and polydispersity index (PdI) of the nanoparticles are given in <xref ref-type="table" rid="T6">Table 6</xref>. PdI values indicates the uniformity of the sizes of the nanoparticles in dispersions. According to the results (<xref ref-type="fig" rid="F5">Figure 5</xref>; <xref ref-type="table" rid="T6">Table 6</xref>), SGV NPs, SLL NPs and empty NPs have average diameters of 487.1, 582.8, 685.8&#xa0;nm; sizes at peak maximum 244.2, 422.2, 350.3&#xa0;nm and PdI values of 0.471, 0.407, 0.660. <xref ref-type="fig" rid="F5">Figure 5</xref> also shows that there is no aggregates or large particles in the dispersion system. The Z-average values and the size at peak maximum showed that the particles are at the nanoscale with reasonable polidispersity index (PdI) values (<xref ref-type="bibr" rid="B46">Soltanzadeh et al., 2021</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Intensity-based particle size distribution of SGV NPs: SLL NPs and empty NPs.</p>
</caption>
<graphic xlink:href="fphar-16-1508762-g005.tif"/>
</fig>
<table-wrap id="T6" position="float">
<label>TABLE 6</label>
<caption>
<p>Average diameter, size at peak maximum and poly-dispersity index (PdI), encapsulation efficiency (EE) and loading capacity (LC) of SGV NPs, SLL NPs and empty NPs.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left"/>
<th align="left">Z-Average (d.nm)</th>
<th align="left">Size (d.nm)</th>
<th align="left">PdI</th>
<th align="left">Encapsulation efficiency, EE (%)</th>
<th align="left">Loading capacity, LC (%)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">SGV NPs</td>
<td align="left">357.0</td>
<td align="left">282.4</td>
<td align="left">0.429</td>
<td align="left">17.66</td>
<td align="left">3.45</td>
</tr>
<tr>
<td align="left">SLL NPs</td>
<td align="left">582.8</td>
<td align="left">422.2</td>
<td align="left">0.407</td>
<td align="left">14.98</td>
<td align="left">3.35</td>
</tr>
<tr>
<td align="left">Empty NPs</td>
<td align="left">685.8</td>
<td align="left">350.3</td>
<td align="left">0.660</td>
<td align="left">-</td>
<td align="left">-</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Encapsulation of the SGV and SLL extracts shifted the average diameters of the nanoparticles to smaller particle sizes with lower PdI values indicating improved uniformity of the particle size distribution, in comparison with the empty NPs. This result expresses that the presence of the phenolic rich extracts showed surface activity and improved the emulsifying properties of the NPs (<xref ref-type="bibr" rid="B21">Flamminii et al., 2020</xref>).</p>
<p>The encapsulation efficiency (EE) and the loading capacity (LC) of the nanoparticles were calculated using the <xref ref-type="disp-formula" rid="e1">Equation 1</xref> and <xref ref-type="disp-formula" rid="e2">Equation 2</xref>, respectively. EE was found to be 17.66% for SGV NPs and 14.98% for SLL NPs while LC was found to be 3.45% for SGV NPs and 3.35% for SLL NPs as given in <xref ref-type="table" rid="T6">Table 6</xref>. SLL and SGV were shown similar efficiency and capacity for the encapsulation with sodium alginate matrix and the calculated results showed the encapsulation limitations of these extracts across alginate chains (<xref ref-type="bibr" rid="B46">Soltanzadeh et al., 2021</xref>).</p>
<p>
<italic>In-vitro</italic> release abilities of the SGV NPs and SLL NPs were studied in PBS medium to show their capability to be used in drug delivery applications. Release profiles of SGV NPs and SLL NPs were shown in <xref ref-type="fig" rid="F6">Figure 6</xref>. There is a burst release effect in the first hour for the both delivery systems which was followed by a gradual release in the following hours. About 90% of the SGV was released gradually from the SGV NPs in the next 5&#xa0;h while about 80% of the SLL was released gradually from the SLL NPs in the next 5&#xa0;h (<xref ref-type="bibr" rid="B33">Ji et al., 2019</xref>). The release profile of the both encapsulated nanoparticles showed that the formulations produced are promising natural drug delivery systems synthesized using the green chemistry approach.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>
<italic>In vitro</italic> release profiles of encapsulated SGV and SLL.</p>
</caption>
<graphic xlink:href="fphar-16-1508762-g006.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>Phenolic metabolites were shown to have potent antioxidant, antimicrobial, anticarcinogenic, antiinflammatory, anti-urease and anticholinesterase properties in the literature review. Thus far, over 8,000 phenolic metabolites have been found in naturally occurring sources (<xref ref-type="bibr" rid="B57">Sotirios et al., 2020</xref>; <xref ref-type="bibr" rid="B58">Yuanyuan et al., 2022</xref>). In <italic>Sideritis</italic> species (<italic>S. scardica</italic> and <italic>S. raeseri</italic>), 5,7-hydroxyflavones (apigenin and luteolin) and 8-hydroxyflavones (hypolaetin (8-OH luteolin)) and their derivatives are present as phenolic substances. Later researches have verified the existence of 8-hydroxyflavones such isoscutellarein, hypolaetin, and their methoxy derivatives, which are extremely distinctive for <italic>Sideritis</italic> species. Additionally, the following hydroxycinnamic acid derivatives were found in <italic>Sideritis</italic> extracts: <italic>p</italic>-coumaric acid, 3-<italic>O-</italic>caffeoylquinic acid, and 5-<italic>O-</italic>caffeoylquinic acid (the two main representatives of chlorogenic acids) feruloylquinic acid and 4-<italic>O</italic>-glucoside. The other research verified that the chemical makeup of plants from the genus <italic>Sideritis</italic> (samples of <italic>S. scardica</italic> and <italic>S. raeseri</italic>) gathered from the Balkan countries is identical. The phenolic metabolites contained in <italic>Sideritis</italic> species provide strong biological effects to these species (<xref ref-type="bibr" rid="B41">Petreska et al., 2011</xref>; <xref ref-type="bibr" rid="B31">Ibraliu et al., 2015</xref>; <xref ref-type="bibr" rid="B47">Stanoeva et al., 2015</xref>; <xref ref-type="bibr" rid="B17">Dorota et al., 2020</xref>).</p>
<p>The Soxhlet technique was used to create a methanol extract from the aerial parts of the <italic>S. libanotica</italic> subsp. <italic>linearis</italic> (SLL<italic>)</italic>, and the IC<sub>50</sub> value for its ability to scavenge DPPH radicals was found to be 109&#xa0;&#x3bc;g/mL. It was discovered that it demonstrated less radical scavenging activity than the reference standards, ascorbic acid (3.80&#xa0;&#x3bc;g/mL) and BHT (18.00&#xa0;&#x3bc;g/mL) (<xref ref-type="bibr" rid="B50">Tepe et al., 2006</xref>). In another study, the analysis of total phenolic metabolites in 80% methanol extract of SLL plant was investigated and it was found that the extract contained 10.33 &#xb1; 0.45&#xa0;g GAE/kg dw phenolic extract.</p>
<p>The value of the DPPH radical scavenging activity is 14.08 &#xb1; 0.86&#xa0;g dw/g DPPH in appearance. The primary metabolites in this extract were identified as <italic>p</italic>-coumaric, caffeic, ferulic acids, quercetin, morin, and apigenin (<xref ref-type="bibr" rid="B16">Dincer et al., 2017</xref>). Furthermore, 3&#x2032;-<italic>O</italic>-methylhypolaetin 7-<italic>O</italic>-[6&#x2033;- <italic>O</italic>-acetyl-&#x3b2;D-allopyranosyl-(1-2)]-6&#x2033;-<italic>O</italic>-acetyl-&#x3b2;-D-glucopyranoside and sideridiol, which have been found to have potent antioxidant activity, have been isolated from the methanol extract of this plant (<xref ref-type="bibr" rid="B15">Demirtas et al., 2011</xref>). Investigations on the cytotoxic effects of the SLL plant&#x2019;s methanol extract on Vero, HeLa, and C6 cell lines revealed that it was effective at cytotoxic activities at a concentration of 250&#xa0;&#x3bc;g/mL (<xref ref-type="bibr" rid="B14">Demirtas et al., 2009</xref>). It was discovered that <italic>S. aureus</italic> was resistant to the methanol extract of the SLL plant (MIC: 64&#xa0;&#x3bc;g/mL). Additionally, a strong scavenging action of the DPPH radical (IC50: 0.0133&#xa0;mg/mL) was discovered (<xref ref-type="bibr" rid="B27">G&#xfc;ven et al., 2021</xref>).</p>
<p>In this study, the antioxidant activity of different extracts from the <italic>Sideritis libanotica</italic> subsp. <italic>linearis</italic> species was examined. It was determined that the 70% ethanol extract (IC<sub>50</sub>:39&#xa0;&#x3bc;g/mL) of the plant showed significant DPPH radical scavenging activity. Compared to the above study, this study determined that 70% ethanol extract had higher radical scavenging activity potential. It is thought that the difference between the studies is due to agroecological conditions, the time of collection and the solvent used in the extraction process. In addition, in this study, the phenolic metabolites contained in 70% ethanol extract of the plant were analysed in amounts similar to the above studies. The chemicals from <italic>Sideritis</italic> species that were examined in this study yielded findings that were consistent with those of other investigations. In the literature review of the <italic>Sideritis germanicopolitana</italic> subsp. <italic>viridis</italic> (SGV), no detailed study on the chemical composition and biological activities of this species was found. The biological activity and chemical composition of various extracts and bioactive extract-loaded nanoparticles of these two <italic>Sideritis</italic> species were examined in depth for the first time in this study. When the biological activities of 70% ethanol extracts from both <italic>Sideritis</italic> species and nanoparticles loaded with these extracts were compared, it was determined that the extracts had lower activity than the nanoparticles. The actual amount of the extracts calculated by using Loading Capacity (%) values has been considered for the comparison which are 3.45% for SGV and 3.35% for SLL. As in the study, when the biological activities of plant extract-loaded nanoparticles and free forms of the same extracts are compared, there are studies in the literature that the free forms are more active biologically. In our study, the crude plant extract also showed higher activity than the produced nanoformulations. Since crude plant extracts may show toxicity, their direct use in pharmaceutical applications is limited. To solve this problem, plant extracts must be loaded into a carrier system. The advantages of carrier systems are that, in addition to reducing toxicity, they provide controlled release and increase the bioavailability of the active ingredients. As a result, even though the produced nanoparticle showed lower activity than the extract, produced formulation has enhanced its potential to be applied in the treatment. As in our study, when the biological activities of plant extract-loaded nanoparticles and free forms of the same extracts are compared, there are studies in the literature that the free forms are more biologically active. Eventually, in order to be used in real life applicatons, they must be produced into a suitable and safe formulation (<xref ref-type="bibr" rid="B39">Mishra et al., 2021</xref>; <xref ref-type="bibr" rid="B22">Ge et al., 2022</xref>; <xref ref-type="bibr" rid="B35">Maqsoudlou et al., 2022</xref>; Li et al., 2021; <xref ref-type="bibr" rid="B45">Sinlapapanya et al., 2024</xref>).</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>5 Conclusion</title>
<p>Bioactive extracts of SLL and SGV were encapsulated into natural polymer-based nanoparticles using the green chemistry approach without using any additives or surface-active agents following an environmentally friendly route, in this study. Physicochemical characterization of the nanoparticles was done besides the <italic>in vitro</italic> release study of the active agents which show the potential of these formulations as drug delivery systems for the controlled release and diminished side effects. The findings of this study showed that the 70% ethanol extracts from SLL and SGV had the highest antiurease, anticholinesterase, and antioxidant properties. Along with producing and characterizing nanoparticles from these extracts, a qualitative and quantitative analysis of the phytochemical contents of these extracts was conducted. It was also analyzed that luteolin and <italic>p</italic>-coumaric acid was observed in high content in the SGV extract while rosmarinic acid, caffeic acid and <italic>p</italic>-coumaric acid was found in high concentration in SLL extract. Crude extracts and nanoparticles loaded with extracts from both <italic>Sideritis</italic> species were compared for their antioxidant, antiurease, and anticholinesterase properties. The data demonstrated that the crude extracts had higher biological activity potential than the nanoparticles. The nanoparticle formulations developed as a result of this work have significant biological activities, it is thought that these formulations can be used as antioxidants, antiurease and anticholinesterase agents in the future after their cytotoxic effects and <italic>in vivo</italic> experiments are performed.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>TT: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing&#x2013;original draft, Writing&#x2013;review and editing. BY: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing&#x2013;original draft. SHNN: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing&#x2013;review and editing. ME: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing&#x2013;original draft. DT: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing&#x2013;original draft. I&#x15e;: Validation, Visualization, Writing&#x2013;original draft, Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision. T&#x15e;: Investigation, Methodology, Resources, Writing&#x2013;original draft. E&#xc7;S: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing&#x2013;review and editing. AS: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing&#x2013;review and editing. OK: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing&#x2013;review and editing. HKE: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing&#x2013;original draft.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was funded by the Scientific and Technological Research Council of T&#xfc;rkiye (TUBITAK) 2209/A Grant No 1919B012102980.</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khare</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Phytochemical delivery through nanocarriers: a review</article-title>. <source>Colloids Surf. B Biointerfaces.</source> <volume>197</volume>, <fpage>111389</fpage>. <pub-id pub-id-type="doi">10.1016/j.colsurfb.2020.111389</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anand</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>A review on cholinesterase inhibitors for Alzheimer&#x2019;s disease</article-title>. <source>Arch. Pharm. Res.</source> <volume>36</volume> (<issue>4</issue>), <fpage>375</fpage>&#x2013;<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1007/s12272-013-0036-3</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anirudhan</surname>
<given-names>T. S.</given-names>
</name>
<name>
<surname>Anila</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Franklin</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Synthesis characterization and biological evaluation of alginate nanoparticle for the targeted delivery of curcumin</article-title>. <source>Mater Sci. Eng. C</source> <volume>78</volume>, <fpage>1125</fpage>&#x2013;<lpage>1134</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2017.04.116</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Apak</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>G&#xfc;&#xe7;l&#xfc;</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>&#xd6;zy&#xfc;rek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Karademir</surname>
<given-names>S. E.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Novel total antioxidant capacity index for dietary polyphenols and vitamins c and e, using their cupric ion reducing capability in the presence of neocuproine: CUPRAC method</article-title>. <source>J. Agric. Food Chem.</source> <volume>52</volume> (<issue>26</issue>), <fpage>7970</fpage>&#x2013;<lpage>7981</lpage>. <pub-id pub-id-type="doi">10.1021/jf048741x</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eruygur</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sozmen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ergul</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ergul</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akpulat</surname>
<given-names>H. A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Evaluation of various biological activities of endemic <italic>Sideritislibanotica</italic> Extracts</article-title>. <source>Not. Sci. Biol.</source> <volume>11</volume> (<issue>2</issue>), <fpage>210</fpage>&#x2013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.15835/nsb11210442</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azizian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nabati</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sharifi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Siavoshi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mahdavi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Amanlou</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Large-scale virtual screening for the identification of new <italic>Helicobacter pylori</italic> urease inhibitor scaffolds</article-title>. <source>J. Mol. Model.</source> <volume>18</volume> (<issue>7</issue>), <fpage>2917</fpage>&#x2013;<lpage>2927</lpage>. <pub-id pub-id-type="doi">10.1007/s00894-011-1310-2</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bakadia</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Boni</surname>
<given-names>B. O. O.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>A. A. Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The impact of oxidative stress damage induced by the environmental stressors on COVID-19</article-title>. <source>Life Sci.</source> <volume>264</volume>, <fpage>118653</fpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2020.118653</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barja</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Free radicals and aging</article-title>. <source>Trends Neurosci.</source> <volume>27</volume> (<issue>10</issue>), <fpage>595</fpage>&#x2013;<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2004.07.005</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Aksit</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Antifungal activity of essential oils and plant extracts from <italic>Sideritisgermanicopolitana</italic> BORNM. Growin in Turkey</article-title>. <source>EJBPC.</source> <volume>26</volume> (<issue>2</issue>), <fpage>333</fpage>&#x2013;<lpage>337</lpage>.</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benzie</surname>
<given-names>I. F.</given-names>
</name>
<name>
<surname>Strain</surname>
<given-names>J. J.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>The ferric reducing ability of plasma (FRAP) as a measure of &#x201c;antioxidant power&#x201d;: the FRAP assay</article-title>. <source>Anal. Biochem.</source> <volume>239</volume>, <fpage>70</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1006/abio.1996.0292</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xc7;al&#x131;&#x15f;kan Salihi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kabacao&#x11f;lu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>K&#x131;rkulak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>&#x160;iller</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Graphene oxide as a new generation adsorbent for the removal of antibiotics from waters</article-title>. <source>Sep. Sci. Technol.</source> <volume>56</volume> (<issue>3</issue>), <fpage>453</fpage>&#x2013;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1080/01496395.2020.1717533</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#x00C7;a&#x006C;&#x0131;&#x015F;kan Salihi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zarrabi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zarepour</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>G&#x00FC;rbo&#x011F;a</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hasan Niari Niar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>&#x00D6;zakp&#x131;nar</surname>
<given-names>&#x00D6;. B.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Ambient pressure dried graphene oxide-silica composite aerogels as pharmaceutical nanocarriers</article-title>. <source>Journal of Sol-Gel Science and Technology</source> <volume>113</volume> (<issue>2</issue>), <fpage>548</fpage>&#x2013;<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1007/s10971-024-06624-1</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Silva</surname>
<given-names>N. D.</given-names>
</name>
<name>
<surname>Attanayake</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Karunaratne</surname>
<given-names>D. N.</given-names>
</name>
<name>
<surname>Arawwawala</surname>
<given-names>L. D. A. M.</given-names>
</name>
<name>
<surname>Pamunuwa</surname>
<given-names>G. K.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Synthesis and bioactivity assessment of Coccinia grandis L. extract encapsulated alginate nanoparticles as an antidiabetic drug lead</article-title>. <source>J. Microencapsul.</source> <volume>41</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1080/02652048.2023.2282964</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demirhan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>BingolOzakpinar</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>&#xc7;al&#x131;&#x15f;kan Salihi</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Green and one step modification of graphene oxide using natural substances</article-title>. <source>Fuller. nanotub. Carbon Nanostructures</source> <volume>29</volume> (<issue>9</issue>), <fpage>716</fpage>&#x2013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1080/1536383x.2021.1884074</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demirtas</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Sahin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ayhan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tekin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Telci</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Antiproliferative effects of the methanolic extracts of <italic>Sideritis libanotica</italic> Labill. subsp. linearis</article-title>. <source>Rec. Nat. Prod.</source> <volume>3</volume> (<issue>2</issue>), <fpage>104</fpage>&#x2013;<lpage>109</lpage>.</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Demirtas</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ayhan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sahin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Aksit</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Elmastas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Telci</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Antioxidant activity and chemical composition of <italic>Sideritis libanotica</italic> Labill</article-title>. <source>Ssp. linearis (Bentham) Borm. Lamiaceae. Nat.Prod. Res.</source> <volume>25</volume> (<issue>16</issue>), <fpage>1512</fpage>&#x2013;<lpage>1523</lpage>. <pub-id pub-id-type="doi">10.1080/14786410903293191</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dincer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Torun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tontul</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Topuz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sahin-Nadeem</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gokturk</surname>
<given-names>R. S.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Phenolic composition and antioxidant activity of <italic>Sideritis lycia</italic> and <italic>Sideritis libanotica</italic> subsp. <italic>linearis</italic>: effects of cultivation, year and storage</article-title>. <source>J. Appl. Res. Med. Aromat. Plants</source> <volume>5</volume>, <fpage>26</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.jarmap.2016.09.006</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorota</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kamila</surname>
<given-names>K.-W.</given-names>
</name>
<name>
<surname>Joanna</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Kacper</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Polyphenols and other bioactive compounds of <italic>Sideritis</italic>plants and their potential biological activity</article-title>. <source>Molecules</source> <volume>25</volume>, <fpage>3763</fpage>&#x2013;<lpage>3780</lpage>. <pub-id pub-id-type="doi">10.3390/molecules25163763</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellman</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Courtney</surname>
<given-names>K. D.</given-names>
</name>
<name>
<surname>Andres Jr</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Featherstone</surname>
<given-names>R. M.</given-names>
</name>
</person-group> (<year>1961</year>). <article-title>A New and rapid colorimetric determination of acetylcholinesterase activity</article-title>. <source>Biochem. Pharmacol.</source> <volume>7</volume> (<issue>2</issue>), <fpage>88</fpage>&#x2013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(61)90145-9</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>Y. Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Free radicals, antioxidants, and nutrition</article-title>. <source>Nutrition</source> <volume>18</volume> (<issue>10</issue>), <fpage>872</fpage>&#x2013;<lpage>879</lpage>. <pub-id pub-id-type="doi">10.1016/s0899-9007(02)00916-4</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hanin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Lachman</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2012</year>). <source>Alzheimer&#x2019;s and Parkinson&#x2019;s diseases: strategies for research and development</source> (<publisher-name>Springer Science and Business Media</publisher-name>), <volume>29</volume>.</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flamminii</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Di Mattia</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Nardella</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chiarini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Valbonetti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Neri</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Structuring alginate beads with different biopolymers for the development of functional ingredients loaded with olive leaves phenolic extract</article-title>. <source>Food Hydrocoll.</source> <volume>108</volume>, <fpage>105849</fpage>. <pub-id pub-id-type="doi">10.1016/j.foodhyd.2020.105849</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Formisano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Oliviero</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rigano</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Senator</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Comparative chemical composition and antioxidant properties of the essential oils of three sideritis libanotica subspecies</article-title>. <source>Nat. Prod. Commun.</source> <volume>10</volume> (<issue>6</issue>), <fpage>1075</fpage>&#x2013;<lpage>1078</lpage>. <pub-id pub-id-type="doi">10.1177/1934578X1501000670</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ge</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The Antioxidant effect of the metal and metal-oxide nanoparticles</article-title>. <source>Antioxidants</source> <volume>11</volume> (<issue>2022</issue>), <fpage>791</fpage>&#x2013;<lpage>797</lpage>. <pub-id pub-id-type="doi">10.3390/antiox11040791</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghous</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Akhtar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nasim</surname>
<given-names>F. U. H.</given-names>
</name>
<name>
<surname>Choudhry</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Screening of selected medicinal plants for urease inhibitory activity</article-title>. <source>Biol. Med.</source> <volume>2</volume>, <fpage>64</fpage>&#x2013;<lpage>69</lpage>.</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonz&#xe1;lez-Burgos</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Carretero</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>G&#xf3;mez-Serranillos</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>
<italic>Sideritis</italic> spp.: uses, chemical composition and pharmacological activities-A review</article-title>. <source>J. Ethnopharmacol.</source> <volume>135</volume> (<issue>2</issue>), <fpage>209</fpage>&#x2013;<lpage>225</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2011.03.014</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graham</surname>
<given-names>D. Y.</given-names>
</name>
<name>
<surname>Miftahussurur</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>
<italic>Helicobacter pylori</italic> urease for diagnosis of <italic>Helicobacter pylori</italic> infection: a mini review</article-title>. <source>J. Adv. Res.</source> <volume>13</volume>, <fpage>51</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.jare.2018.01.006</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xfc;lsoy Toplan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>K&#xfc;rk&#xe7;&#xfc;o&#x11f;lu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>G&#xf6;ger</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ta&#x15f;k&#x131;n</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Civa&#x15f;</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>&#x130;&#x15f;can</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Phytochemical screening and biological evaluation of Salvia hydrangea DC. ex Benth. growing in eastern Anatolia</article-title>. <source>S Afr. J. Bot.</source> <volume>147</volume>, <fpage>799</fpage>&#x2013;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1016/j.sajb.2022.03.021</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>G&#xfc;ven</surname>
<given-names>U. M.</given-names>
</name>
<name>
<surname>Kayiran</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Ayg&#xfc;l</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nenni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kirici</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Design of microemulsion formulations loaded <italic>Scutellariasalviifolia</italic> Benth, <italic>Sideritislibanotica</italic> Labill. subsp. <italic>linearis</italic> (Bentham) Bornm, and <italic>Ziziphoraclinopodioides</italic> Lam. extracts from Turkey and <italic>in vitro</italic> evaluation of their biological activities</article-title>. <source>Turk. J. Bot.</source> <volume>45</volume>, <fpage>789</fpage>&#x2013;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.3906/bot-2108-50</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashem</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Motawea</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kamel</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Bary</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Fabrication and characterization of electrospun nanofibers using biocompatible polymers for the sustained release of venlafaxine</article-title>. <source>Sci. Rep.</source> <volume>12</volume> (<issue>1</issue>), <fpage>18037</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-22878-7</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hcini</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lozano-P&#xe9;rez</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Luis Cenis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu&#xed;lez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jos&#xe9; Jord&#xe1;n</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Extraction and encapsulation of phenolic compounds of tunisian rosemary (Rosmarinus officinalis L.) extracts in silk fibroin nanoparticles</article-title>. <source>Plants</source> <volume>10</volume> (<issue>11</issue>), <fpage>2312</fpage>. <pub-id pub-id-type="doi">10.3390/plants10112312</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holst</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants</article-title>. <source>CRBIOT</source> <volume>19</volume> (<issue>2008</issue>), <fpage>73</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2008.03.003</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ibraliu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Trendafilova</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>An&#x111;elkovi&#x107;</surname>
<given-names>B. D.</given-names>
</name>
<name>
<surname>Qazimi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Go&#x111;evac</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Shengjergji</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Comparative study of balkan <italic>sideriti</italic>s species from Albania, Bulgaria and Macedonia</article-title>. <source>Eur. J. Med. Plants.</source> <volume>5</volume>, <fpage>328</fpage>&#x2013;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.9734/ejmp/2015/14389</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jahangirian</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lemraski</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Rafiee-Moghaddam</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Abdollahi</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine</article-title>. <source>Int. J. Nanomedicine</source> <volume>12</volume>, <fpage>2957</fpage>&#x2013;<lpage>2978</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S127683</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Green synthesis, characterization and <italic>in vitro</italic> release of cinnamaldehyde/sodium alginate/chitosan nanoparticles</article-title>. <source>Food Hydrocoll.</source> <volume>90</volume>, <fpage>515</fpage>&#x2013;<lpage>522</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodhyd.2018.12.027</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ayran</surname>
<given-names>&#x130;.</given-names>
</name>
<name>
<surname>&#xc7;elik</surname>
<given-names>S. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Essential oil yield and compositions of endemic mountain tea (<italic>Sideritislibanotica</italic>Labill. ssp. <italic>linearis</italic> (Bentham) Borm. and <italic>Sideritisbilgerana</italic> PH Davis) cultivated in Konya ecological conditions of Turkey</article-title>. <source>Int. J. Agric. Environ. Food Sci.</source> <volume>1</volume>, <fpage>204</fpage>&#x2013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.31015/jaefs.18038</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maqsoudlou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Assadpour</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mohebodini</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jafari</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The influence of nanodelivery systems on the antioxidant activity of natural bioactive compounds. Crit</article-title>. <source>Rev. Food Sci</source>. <pub-id pub-id-type="doi">10.1080/10408398.2020.1863907</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Ballesta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gil-Izquierdo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garcia-Viguera</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dominguez-Perles</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Nanoparticles and controlled delivery for bioactive compounds: outlining challenges for new &#x201c;Smartfoods&#x201d;for health</article-title>. <source>Foods.</source> <volume>7</volume>, <fpage>72</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.3390/foods7050072</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez-Perez</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Quintanar-Guerrero</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tapia-Tapia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cisneros-Tamayo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>ZambranoZaragoza</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Alcala-Alcala</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Controlled-release biodegradable nanoparticles: from preparation to vaginal applications</article-title>. <source>Eur. J. Pharm. Sci.</source> <volume>115</volume> (<issue>2018</issue>), <fpage>185</fpage>&#x2013;<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejps.2017.11.029</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Panda</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer&#x2019;s disease (1998-2018)</article-title>. <source>Bioorg. Med. Chem.</source> <volume>27</volume> (<issue>6</issue>), <fpage>895</fpage>&#x2013;<lpage>930</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmc.2019.01.025</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishra</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sahani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pal</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Encapsulation of herbal extracts</article-title>. <source>Sustain. Agric. Rev. 55 Micro Nano Eng. Food Sci.</source> <volume>1</volume>, <fpage>115</fpage>&#x2013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-030-76813-3_5</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xd6;zkan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kr&#xfc;ger</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Schulz</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>&#xd6;zcan</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Essential oil composition of three <italic>Sideritis</italic> species used as herbal teas in Turkey</article-title>. <source>J. Essent. Oil-Bear. Plants</source> <volume>8</volume> (<issue>2</issue>), <fpage>173</fpage>&#x2013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1080/0972060x.2005.10643439</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petreska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stefova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ferreres</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Tom&#xe1;s-Barber&#xe1;n</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Stefkov</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Potential bioactive phenolics of Macedonian <italic>Sideritis</italic>species used for medicinal &#x201c;Mountain Tea&#x201d;</article-title>. <source>Food Chem.</source> <volume>125</volume>, <fpage>13</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2010.08.019</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajaonarivony</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vauthier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Couarraze</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Puisieux</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Couvreur</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Development of a new drug carrier made from alginate</article-title>. <source>J. Pharm. Sci.</source> <volume>82</volume> (<issue>9</issue>), <fpage>912</fpage>&#x2013;<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1002/jps.2600820909</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Severino</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>C. F.</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>L. N.</given-names>
</name>
<name>
<surname>de Lima Oliveira</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Campos</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Souto</surname>
<given-names>E. B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Alginate nanoparticles for drug delivery and targeting</article-title>. <source>Curr. Pharm. Des.</source> <volume>25</volume> (<issue>11</issue>), <fpage>1312</fpage>&#x2013;<lpage>1334</lpage>. <pub-id pub-id-type="doi">10.2174/1381612825666190425163424</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sevindik</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>G&#xfc;be&#x15f;</surname>
<given-names>&#x130;.</given-names>
</name>
<name>
<surname>Murathan</surname>
<given-names>Z. T.</given-names>
</name>
<name>
<surname>T&#xfc;men</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Determination of total phenolic content, total flavonoid content and total antioxidant capacity in some endemic <italic>Sideritis</italic>L. (Lamiaceae) species grown in Turkey</article-title>. <source>Eur. J. Biol.</source> <volume>11</volume> (<issue>2</issue>), <fpage>260</fpage>&#x2013;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.5281/zenodo.4660074</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinlapapanya</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Buatong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Palamae</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nazeer</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Prodpran</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Ethanolic cashew leaf extract encapsulated in tripolyphosphate&#x2013;chitosan complexes: characterization, antimicrobial, and antioxidant activities</article-title>. <source>Colloids Interfaces</source> <volume>8</volume> (<issue>2024</issue>), <fpage>52</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.3390/colloids8050052</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soltanzadeh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peighambardoust</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Ghanbarzadeh</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Mohammadi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lorenzo</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Chitosan nanoparticles as a promising nanomaterial for encapsulation of pomegranate (<italic>Punica granatum</italic> L.) peel extract as a natural source of antioxidants</article-title>. <source>Nanomaterials</source> <volume>11</volume> (<issue>6</issue>), <fpage>1439</fpage>. <pub-id pub-id-type="doi">10.3390/nano11061439</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sotirios</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Charalampos</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vassiliki</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Phenolic acids of plant origin&#x2014;a review on their antioxidant activity <italic>in vitro</italic> (o/w emulsion systems) along with their <italic>in vivo</italic> health biochemical properties</article-title>. <source>Foods</source> <volume>9</volume> (<issue>4</issue>), <fpage>534</fpage>&#x2013;<lpage>537</lpage>. <pub-id pub-id-type="doi">10.3390/foods9040534</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanoeva</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Stefova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stefkov</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kulevanova</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alipieva</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bankova</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Chemotaxonomic contribution to the <italic>Sideritis</italic> species dilemma on the Balkans</article-title>. <source>Biochem. Syst. Ecol.</source> <volume>61</volume>, <fpage>477</fpage>&#x2013;<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1016/j.bse.2015.07.008</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stingl</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>De Reuse</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Staying alive overdosed: how does <italic>Helicobacter pylori</italic> control urease activity?</article-title> <source>Int. J. Med. Microbiol.</source> <volume>295</volume> (<issue>5</issue>), <fpage>307</fpage>&#x2013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2005.06.006</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ta&#x15f;k&#x131;n</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Y&#x131;lmaz</surname>
<given-names>B. N.</given-names>
</name>
<name>
<surname>Ta&#x15f;k&#x131;n</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Omurtag</surname>
<given-names>G. Z.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The influence of different extraction methods/solvents on composition, biological activities and ADMET predictions of phenolics in Tribulus terrestris</article-title>. <source>Braz. Arch. Biol. Technol.</source> <volume>64</volume>, <fpage>e21210249</fpage>. <pub-id pub-id-type="doi">10.1590/1678-4324-2021210249</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tepe</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sokmen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akpulat</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Yumrutas</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Sokmen</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Screening of antioxidative properties of the methanolic extracts of <italic>Pelargonium endlicherianum</italic>Fenzl</article-title>. <source>Verbascumwiedemannianum Fisch. &#x26;Mey., SideritislibanoticaLabill. Subsp. linearis(Bentham)</source>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2005.05.046</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valko</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leibfritz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Moncol</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cronin</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Mazur</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Telser</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Free radicals and antioxidants in normal physiological functions and human disease</article-title>. <source>Int. J.Biochem. Cell. Biol.</source> <volume>39</volume> (<issue>1</issue>), <fpage>44</fpage>&#x2013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2006.07.001</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>&#xc7;al&#x131;&#x15f;kan Salihi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>&#x160;iller</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Green reduction of graphene oxide using alanine</article-title>. <source>Mater. Sci. Eng. C</source> <volume>72</volume>, <fpage>1</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2016.11.017</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jinglou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yaling</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yongfang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liming</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Antioxidant, free radical scavenging, anti-inflammatory and hepatoprotective potential of the extract from <italic>Parathelypterisnipponica</italic> (Franch.et Sav.) Ching</article-title>. <source>J. Ethnopharmacol.</source> <volume>130</volume>, <fpage>521</fpage>&#x2013;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2010.05.039</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuanyuan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ping</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guanghui</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guanghui</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>A brief review of phenolic compounds identified from plants: their extraction, analysis, and biological activity</article-title>. <source>Nat. Prod. Commun.</source> <volume>17</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1177/1934578X211069721</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kokini</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Encapsulation of tannins and tannin-rich plant extracts by complex coacervation to improve their physicochemical properties and biological activities: a review</article-title>. <source>Crit. Rev. Food Sci. Nutr.</source> <volume>63</volume> (<issue>18</issue>), <fpage>3005</fpage>&#x2013;<lpage>3018</lpage>. <pub-id pub-id-type="doi">10.1080/10408398.2022.2075313</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>